HEERMA PETER (Chief Commercial Officer) sold 4.5% of their position (5.59K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $195.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/4/2025ACC: 0001789617-25-000007
Officer· Chief Commercial Officer
Since Oct 2019
-6.67K
Net shares
Net seller
$195.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
6.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.59K
Price / share
$35.00
Trade value
$195.69K
% of position
4.5%
10/31/2025
124.66K→119.07K
Common Stock
Direct
Shares
−1.08K
Price / share
—
Trade value
—
% of position
0.9%
11/3/2025
119.07K→117.99K
Total
Net shares
−6.67K
Net value
-$195.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2025 | S · Sale | −5.59K | $35.00 | $195.69K | 4.5% | 124.66K | 119.07K |
| Common Stock Direct | 11/3/2025 | G · Gift | −1.08K | — | — | 0.9% | 119.07K | 117.99K |
| Total | −6.67K | -$195.69K | ||||||
Derivative Transactions0
No derivative transactions reported